Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses.

Lazarus, JV; Safreed-Harmon, K; Stumo, SR; Jauffret-Roustide, M; Maticic, M; Reic, T; Schatz, E; Tallada, J; Harris, M; Hep-CORE Study Group; (2017) Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses. The International journal on drug policy. ISSN 0955-3959 DOI: https://doi.org/10.1016/j.drugpo.2017.05.054

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.drugpo.2017.05.054

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar